1 / 2

Supplementary Figure 1.

Supplementary Figure 1. A. 30. p < 0.001. p < 0.001. 20. IL-7 Concentration ( pg / mL ). 10. 0. D1-2. D3-4. HV. B. 200. 150. 100. sCD127 concentration ( ng /ml). 50. 0. D1-2 NoInf. D1-2 Inf. D3-4 NoInf. D3-4 Inf. Supplementary Figure 2.

ivana-avila
Télécharger la présentation

Supplementary Figure 1.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary Figure 1. A 30 p < 0.001 p < 0.001 20 IL-7 Concentration (pg / mL) 10 0 D1-2 D3-4 HV B 200 150 100 sCD127 concentration (ng/ml) 50 0 D1-2 NoInf D1-2 Inf D3-4 NoInf D3-4 Inf

  2. Supplementary Figure 2. A. Survival curves based on sCD127 (D1) and SAPSII sCD127 ≤ 48.78 - SAPSII ≤ 59 sCD127 ≤ 48.78 - SAPSII > 59 sCD127 > 48.78 - SAPSII ≤ 59 sCD127 > 48.78 - SAPSII > 59 B. Survival curves based on sCD127 (D3) and SAPSII sCD127 ≤ 41.56 - SAPSII ≤ 59 sCD127 ≤ 41.56 - SAPSII > 59 sCD127 > 41.56 - SAPSII ≤ 59 100 100 80 80 sCD127 > 41.56 - SAPSII > 59 60 60 Percent survival Percent survival 40 40 20 20 0 0 0 10 20 30 0 10 20 30 Days Days

More Related